You haven't searched anything yet.
HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. It is estimated that norovirus causes nearly 700 million cases of illness and more than 200,000 deaths worldwide per year with significant additional economic and social burdens.
We are founded on the legacies of leading vaccine developers that inspire us to have a positive impact on human health and build a company that equalizes opportunity for people around the world by removing barriers of health inequity. Our aim is to have a global impact on human health; we believe the best way to achieve this impact is by developing novel vaccines for severe and life-threatening diseases.
Objectives / Overview:
The Development Strategy Project Coordinator will work with a cross-functional team across R&D, including but not limited to, Clinical Development, Clinical Operations, and Clinical Assay development and other sub-teams within CMO. This individual will understand overall R&D-related activities and track CMO key activities consistently in detail. The Project Coordinator will contribute to developing and sustaining effective Project Management business processes within CMO Team, while coordinating and managing the R&D-related activities.
Responsibilities:
Project Management Support
HilleVax is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status. We welcome all to apply.
Full Time
$115k-145k (estimate)
03/04/2024
06/30/2024